Back
FuelCell Energy 10K Form
Sell
29
FCEL
FuelCell Energy
Last Price:
0.90
Seasonality Move:
-7.22%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2023-09-11 | 10Q | FCEL/FuelCell Energy Quarterly |
2023-06-08 | 10Q | FCEL/FuelCell Energy Quarterly |
2023-03-09 | 10Q | FCEL/FuelCell Energy Quarterly |
2022-09-08 | 10Q | FCEL/FuelCell Energy Quarterly |
2022-06-09 | 10Q | FCEL/FuelCell Energy Quarterly |
2022-03-10 | 10Q | FCEL/FuelCell Energy Quarterly |
Receive FCEL News And Ratings
See the #1 stock for the next 7 days that we like better than FCEL
FCEL Financial Statistics
Sales & Book Value
Annual Sales: | $123.39M |
---|---|
Cash Flow: | $-76.35M |
Price / Cash Flow: | 0 |
Annual Sales: | $1.47 |
Price / Book: | 0.61 |
Profitability
EPS (TTM): | -0.27000 |
---|---|
Net Income (TTM): | $-108.74M |
Gross Margin: | $-10.54M |
Return on Equity: | -14.65% |
Return on Assets: | -11.88% |
FuelCell Energy Earnings Forecast
Key FuelCell Energy Financial Ratios
- The Gross Profit Margin over the past 32 years for FCEL is -8.54%.
- The Selling, General & Administrative Expenses for FCEL have been equal to 52.29% of Gross Profit Margin.
- The Research & Development expenses have been 49.45% of Revenue.
- The Interest Expense is -6.74% of Operating Income.
- The Net Earning history of FCEL is -87.17% of Total Revenues.
- Per Share Earnings over the last 32 years have been positive in 18 years.
FuelCell Energy Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Electrical Equipment |
Sector: | Industrials |
Current Symbol: | FCEL |
CUSIP: | 35952H |
Website: | fuelcellenergy.com |
Debt
Debt-to-Equity Ratio: | 0.18 |
---|---|
Current Ratio: | 8.26 |
Quick Ratio: | 6 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
FCEL Technical Analysis vs Fundamental Analysis
Sell
29
FuelCell Energy (FCEL)
is a Sell
Is FuelCell Energy a Buy or a Sell?
-
FuelCell Energy stock is rated a Sell
The current FuelCell Energy [FCEL] share price is $0.90. The Score for FCEL is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.